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ABSTRACT
Transcription factor IIS (TFIIS) stimulates RNA
cleavage by RNA polymerase II by allowing back-
tracked enzymes to resume transcription elongation.
Yeast cells do not require TFIIS for viability, unless
they suffer severe transcriptional stress due to
NTP-depleting drugs like 6-azauracil or mycophenolic
acid. In order to broaden our knowledge on the role of
TFIIS under transcriptional stress, we carried out a
genetic screening for suppressors of TFIIS-lacking
cells’ sensitivity to 6-azauracil and mycophenolic
acid. Five suppressors were identified, four of which
were related to the transcriptional regulation of those
genes encoding ribosomal components [rRNAs and
ribosomal proteins (RP)], including global regulator
SFP1. This led us to discover that RNA polymerase II
is hypersensitive to the absence of TFIIS under NTP
scarcity conditions when transcribing RP genes. The
absence of Sfp1 led to a profound alteration of the
transcriptional response to NTP-depletion, thus
allowing the expression of RP genes to resist these
stressful conditions in the absence of TFIIS. We
discuss the effect of transcriptional stress on
ribosome biogenesis and propose that TFIIS contrib-
utes to prevent a transcriptional imbalance between
rDNA and RP genes.
INTRODUCTION
Gene transcription is played by RNA polymerases, which
require a large set of auxiliary factors ranging from
pre-initiation complex formation to transcription termin-
ation to complete the synthesis of their ﬁnal RNA
transcripts. A relevant category of auxiliary elements is
formed by RNA cleavage factors, which stimulate the
cleavage of the 30-end of nascent RNA by RNA polymer-
ases when they are arrested after backtracking (1).
Transcription factor IIS (TFIIS) is the eukaryal and
archaeal type of the RNA cleavage factor, although
other proteins ubiquitously perform similar functions in
bacteria (1). Transcript cleavage by RNA polymerase II is
catalysed in vitro and in vivo by its intrinsic cleavage
activity, which is strongly stimulated by TFIIS (2,3).
In agreement with its RNA-cleavage stimulation
activity, TFIIS plays an important role during transcrip-
tion elongation (4). In addition, TFIIS has also been
found to be involved in both transcription initiation
regulation (5,6) and the transition from transcription ini-
tiation to elongation (7).
Genetic approaches have shown that TFIIS factors are
essential for cell viability, as with trypanosome (8), and are
required for either correct embryonic development, as in
mouse and Xenopus (9,10), or plant seeds dormancy (11).
In contrast, TFIIS is not essential through the
Saccharomyces cerevisiae life cycle (12). This is particu-
larly striking because RNA polymerase II arrest and
backtracking are very frequent phenomena (13,14), sug-
gesting that spontaneous non-stimulated RNA cleavage is
sufﬁcient for sustaining gene transcription under standard
yeast growing conditions (3).
However, the yeast dst1D mutants lacking TFIIS are
highly sensitive to drugs that impair the de novo synthesis
of NTP, such as 6-azauracil (6AU) and mycophenolic acid
(MPA) (15). These drugs inhibit IMP dehydrogenase, the
key enzyme in the GMP biosynthetic pathway (15). In
response to 6AU or MPA, yeast cells up-regulate the
expression of IMD2, a gene encoding an IMP dehydro-
genase isoenzyme that is resistant to such drugs (16). dst1D
mutants are unable to up-regulate IMD2 (16), which
exhibits a sophisticated transcriptional attenuation mech-
anism in response to GTP levels (17). The over-expression
*To whom correspondence should be addressed. Tel: +34 954 55 09 20; Fax: +34 954 55 71 04; Email: schavez@us.es
Present address:
Fernando Go´mez-Herreros, Genome Damage and Stability Centre, University of Sussex, Brighton, UK.
6508–6519 Nucleic Acids Research, 2012, Vol. 40, No. 14 Published online 27 April 2012
doi:10.1093/nar/gks340
 The Author(s) 2012. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
of IMD2 suppresses the MPA sensitivity of yeast
MPA-sensitive mutants (18). The transcriptional stress
caused by NTP-depleting drugs is partially transient in
wild-type yeast cells due to the up-regulation of IMD2,
whereas it is more intense and permanent in dst1D (16).
Most of the studies conducted on the TFIIS function
have focused on its role during RNA pol II–dependent
transcription. However, it has been shown that TFIIS
and TFIIS-like cleavage factors are also important for
RNA polymerase I- and RNA polymerase III-dependent
transcription (19–23). All this information suggests that
TFIIS generally contributes to the biogenesis of ribo-
somes, whose structural elements are concertedly
transcribed by the three nuclear RNA polymerases (24).
This work addresses the role of TFIIS during transcrip-
tional stress by isolating mutations that are capable of
suppressing yeast dst1D sensitivity to 6AU and MPA.
Most suppressor genes functionally relate to the transcrip-
tional regulation of ribosome synthesis. This fact led us to
discover that TFIIS is required to maintain the transcrip-
tional activity of RNA polymerase II when transcribing
ribosomal protein (RP) genes under transcriptional stress
conditions, and that the absence of TFIIS impairs the
balanced transcription of rDNA and RP genes. These
results are consistent with previous ﬁndings from our lab
indicating a regulation of RNA polymerase II activity
during the transcription elongation of RP genes (25).
MATERIALS AND METHODS
Strains, plasmids and media
The table listing the yeast strains used in this study is included
in the Supplementary Data (Supplementary Table S1).
Suppression screening was performed with the SChY66.9D
strain. Further analyses of simple and double mutants were
performed using the complete deletion mutants obtained
from EUROSCARF, which were isogenic to BY4741.
Tagged strains were also constructed in the BY4741
background. HA-TFIIS strains’ functionality was assayed
by checking resistance to 6AU.WhenRAP1 partial deletions
were utilized, theywere studied in the corresponding original
background, as described elsewhere (26).
For the 6AU treatments, all the strains were trans-
formed with a centromeric plasmid that expresses URA3
and were grown in a complete minimal medium lacking
uracil (SC-URA). MPA and 6-AU (Sigma) were dissolved
directly in growth media up to the desired concentrations.
Growth assays
For the plate assays, yeast cultures were diluted to the
same OD600, and serial dilutions (1:10) were spotted
onto plates. At least three independent experiments were
carried out in all cases.
For calculating the duplication times in the liquid culture,
250ml ﬂasks, containing 50ml SC-Ura cultures, were
inoculated in the presence or the absence of 6AU (25mg/ml)
and incubated at 30C under vigorous agitation (200 rpm).
For themicrocolony assays, cells weremicroencapsulated
in calcium alginate by means of a Cellena microen-
capsulator system (Ingeniatrics) following the
manufacturer’s instructions. A microcapsule population,
mainly containing single cells, was incubated for 20 h in
SC-Ura in the presence or absence of 6AU.After conﬁrming
microcolony development by optical microscopy, the popu-
lation microcolonies was analysed in a COPAS SELECT
ﬂow cytometer (Union Biometrica). Relative microcolony
size wasmonitored bymeasuring self-ﬂuorescence under the
following photomultiplier tube settings: Green (1100),
Yellow (600) and Red (1100). The time of ﬂight minimum
was ﬁxed at 10 and the extinction signal was 1. Sheath ﬂuid
pressure was 4.40–5.19, while sample ﬂuid pressure was set
to maintain a frequency of 15–25 events per second
(2.13–3.63). A detailed protocol of microbial analysis
combining microencapsulation and ﬂow cytometry will be
published elsewhere.
Genetic screening
Suppressor screening was performed by transforming the
SChY66.9D strain with a yeast genomic library which had
been mutagenized by the random insertion of an mTn3-
lacZ/LEU2 transposon (27). Three independent transform-
ations with 0.25mg of a Not1-digested library were plated
onto 10, 20 and 25 mg/ml 6AU plates to allow the isolation
of 14 suppressors of the almost 20 000 transformants. Only
those suppressors that were able to grow on both the 6AU
and MPA plates, and which presented a single insertion
ligated to their suppression phenotype, were selected for
further analyses (Supplementary Table S2). Transposon
insertion sites (Supplementary Figure S1) were identiﬁed
by inverse PCR.
Transcriptional run-on and chromatin immunoprecipitation
Run-on assays were performed as formerly described (28).
Double-strand immobilized probes were obtained by PCR
using the primers listed in Supplementary Table S3.
Membranes were exposed on Fuji BAS screens for 5–7 days
and were developed with a FUJIX FLA3000 device. ChIP
experiments were performed as previously described (28).
The primers utilized are listed in Supplementary Table S3.
RESULTS
Mutations suppressing dst1D sensitivity to NTP-depleting
drugs
Fourteen 6-AU-resistant derivatives from a dst1D strain of
the 19 500 cells mutagenized with an insertion library were
selected as described in the ‘Materials and Methods’
section. Eight of the 6AU-resistant clones were found to
also grow in the presence of MPA. Double-resistant
mutants were crossed to check monogenicity and were
PCR-analysed to map the insertion locus. Five DAS
(after dst1D 6AU sensitivity) genes were ﬁnally identiﬁed
(Supplementary Figure S1). DAS1 (YJL149W) encodes a
putative SCF ubiquitin ligase F-box protein of unknown
function (29). The other DAS genes (YLR403W,
YHR205W, YIL148W and YDR020C) encode four
proteins related to ribosome biogenesis and its control:
ribosomal regulators Sfp1 and Sch9 (30), structural RP
Rpl40A and an uncharacterized protein, which we called
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Das2, which has been previously related to rDNA tran-
scription (31).
Suppressors were conﬁrmed by crossing the correspond-
ing deleted mutants with dst1D in the BY4741 background.
In most cases, double mutants resisted the 6AU concentra-
tions that were inhibitory for the single dst1D mutant
(Supplementary Figure S2A). The only exception was
rpl40AD, which was unable to suppress dst1D in the
BY4741 background, although a plasmid expressing
RPL40A was able to revert the suppression by the original
rpl40A insertional mutation (not shown). In the presence of
the drugs, double mutants were never able to grow as fast as
the wild-type, indicating that the suppression degree was
always partial (Supplementary Figure S2A).
We focused in dst1Dsfp1D for characterizing the genetic
interaction between DST1 and SFP1. The difference in
growth between dst1Dsfp1D and the wild-type seemed to
be shorter in either 6AU or MPA than in the absence of
these drugs (Supplementary Figure S2A), indicating a func-
tional connection between these two genes. The doubling
times calculated from liquid cultures further support this
indication (Supplementary Figure S2B). Nevertheless, the
long doubling time of sfp1D under any condition
complicated the interpretation of the results and implied
the requirement of a large number of generations. In order
to overcome this inconvenience, we developed a growth
assay based on microencapsulation and ﬂow cytometry,
which cuts the observation time from 4 days (visible sfp1D
colonies on plates) to 20h (detectable sfp1D microcolonies
in microcapsules) (Figure 1A and Supplementary
Figure S3A). As shown in Figure 1A, 6AU had no signiﬁ-
cant effect on the wild-type proliferation capacity and the
effect was also minimal for the sfp1D and dst1Dsfp1D cells,
whereas the dst1D cells underwent a dramatic growth arrest
by the drug, resulting in aberrantmicrocolonies. Despite the
intrinsic defect in cell growth that the SFP1 deletion
generated, half the cells from the double mutant incubated
in 6AU were able to develop bigger microcolonies than any
of those produced by the dst1 cell population under the
same conditions (Supplementary Figure S3B). We conclude
that a functional interaction takes place betweenDST1 and
SFP1, which allows a partial suppression of the
6AU-sensitivity phenotype of dst1D by sfp1D.
In our growth assays, 6AU andMPA generally produced
similar results, although minor differences were detected
between the two drugs (Supplementary Figure S2A).
These differences might be related to the secondary targets
of these drugs, likeOMPdecarboxylase, which is speciﬁcally
inhibited by 6AU (32). In addition to these secondary
targets, the common metabolic effect of 6AU and MPA is
the inhibition of IMP dehydrogenases. IMD2 encodes an
IMP dehydrogenease isoenzyme which is resistant to
MPA (33). Sensitivity of dst1D to NTP-depleting drugs
has been connected to the incapacity of dst1D to induce
IMD2 in response to NTP depletion (16). We measured
the mRNA levels of IMD2 in the single and double
mutants after a 90-min incubation with 6AU. Similarly to
the single dst1D mutant, the sfp1D dst1D and sch9D dst1D
double mutants were never able to reach a 2-fold induction
of IMD2, which clearly contrasts with the 17-fold induction
of the wild-type (Figure 1B and Supplementary Figure
S4A). Similar results were obtained with the other das mu-
tations (not shown). sch9D was even able to alleviate the
marked sensitivity of imd2D to MPA (Supplementary
Figure S5). Taken together, these results suggest that the
ability of the dasmutations to suppress dst1D does not cor-
relate with the induction of IMD2, and that das cells can
Figure 1. Sensitivity of dst1D to 6AU and MPA can be partially
suppressed by mutations that alter the transcriptional regulation of
RP genes. (A) Size distribution of the microcolonies developed by
isogenic yeast cells with the indicated genotypes (BY4741 genetic back-
ground), in the absence or presence of 25mg/ml 6AU. Individual cells
were microencapsulated in alginate, incubated for 20h and analysed in a
ﬂow cytometer utilizing self-ﬂuorescence as an indicator of cell size, as
described in the ‘Materials and Methods’ section. Images of representa-
tive microcolonies are shown. Additional microcolonies are shown in
Supplementary Figure S3A. (B) Northern blots showing the effect of
6AU (100mg/ml, 90min) on the mRNA levels of IMD2 in the indicated
isogenic mutants [strains as in (A)]. See quantiﬁcation in Supplementary
Figure S4. Note that a mutant’s ability to suppress the growth defect of
dst1D in the presence of 6AU does not involve the suppression of the
IMD2 up-regulation defect.
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survive and proliferate in the absence of TFIIS under very
stringent NTP stress.
Since most DAS genes were functionally related to the
structural components of ribosomes, we checked whether
other regulators of the genes encoding RPs were able to
suppress dst1D sensitivity to NTP-depleting drugs. We
found that an RAP1 mutant, which lacks the silencing
domain of this transcription factor involved inRP transcrip-
tion (25), was able to partially suppress dst1D (Supple-
mentary Figure S6A) under conditions that do not induce
IMD2 (Figure 1B and Supplementary Figure S4B). Other
RAP1mutants (26) did not show a suppressed phenotype of
dst1D, except RAP1DC, which also lacked the silencing
domain of RAP1 (Supplementary Figure S6A). Likewise,
deletion of the PKA-encoding gene, TPK2, which controls
RP transcription in response to nutritional signals (30),
partially suppressed dst1D sensitivity to NTP-depleting
drugs without inducing IMD2 (Figure 1B, Supplementary
Figures S4CandS6B).We conclude that the alteration of the
transcriptional control of RP genes produced by das muta-
tions allows those cells lacking TFIIS to resist NTP stress.
Effect of 6AU on TFIIS binding and RNA polymerase II
activity on RP genes
In order to evaluate the contribution of TFIIS to tran-
scriptional activity under transcriptional stress, we moni-
tored its occupancy by performing ChIP experiments.
TFIIS was originally described as an RNA pol
II-speciﬁc factor, although TFIIS and TFIIS-like func-
tions have been reported to also impact transcription by
RNA polymerases I and III (19–22). Moreover, a recent
work has demonstrated that TFIIS is bound to any
transcribed locus of the nuclear genome, including the
rDNA regions transcribed by RNA pol I (23). We con-
ﬁrmed the reported binding of TFIIS to rDNA
(Supplementary Figure S7A) and noted a signiﬁcant
decrease in this binding upon 6AU treatment (Figure
2A). rDNA occupancy by RNA pol I was transiently
inﬂuenced by 6AU, as expected for a stressful situation.
However, this response was almost identical in a dst1D
mutant (Figure 2B), suggesting that TFIIS does not play
a major role in rDNA transcription during NTP
depletion.
We also monitored the amount of transcriptionally
active polymerases in dst1D sitting on rDNA by following
transcriptional run-on techniques. The run-on results did
not show lower levels of active RNA pol I molecules in
dst1D (Supplementary Figure S10A). Moreover, the
run-on/Rpa190 ratios, calculated by combining the data
Figure 2. The presence of TFIIS in rDNA did not inﬂuence the distri-
bution of RNA polymerase I along rDNA. (A) The ChIP experiments
reveal a constant binding of TFIIS along rDNA, which partially
decreased upon 100mg/ml 6AU addition. Location of the amplicons
utilized for quantitative PCR are shown in Graph. (B) Variation in
the distribution of RNA polymerase I along rDNA upon 6AU
addition, as measured by the ChIP experiments, using antibodies
against a HA-tagged version of the biggest subunit of the enzyme.
Rpa190 ChIP data are represented as being normalized to a
non-transcribed amplicon within NTS2 (N). Note that addition of
6AU (100 mg/ml) led to a transient decrease in the amount of RNA
polymerase I bound to the transcribed region, and that this decrease
was equally transient in the absence of TFIIS. All the values represent
the average of three independent experiments. Error bars indicate
standard deviation. (C) Variation in the speciﬁc activity of the RNA
polymerases sitting on rDNA caused by 6AU addition (100 mg/ml) to
the wild-type and to an isogenic dst1D strain. RNA polymerase I
speciﬁc activity was expressed as the ratio between variation in the
transcriptional run-on signal (shown in Supplementary Figure S10A)
and variation in the Rpb3 ChIP signal [shown in (B)]. In the latter,
amplicons 3 and 5 were used to achieve the ratios in combination with
the 18S and 25S run-on signals, respectively.
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from Figure 2B and Supplementary Figure S10A, conﬁrm
that TFIIS does not play a relevant role in preserving the
activity of elongating RNA pol I under NTP depletion
since similar proﬁles were observed in dst1D and in the
wild-type (Figure 2C).
We also detected the presence of TFIIS in the genes
encoding RPs and other highly expressed RNA pol
II-dependent genes (Supplementary Figure S7B). We
measured TFIIS binding at three different positions within
the transcribed region of 10 different genes: four RP genes
(RPS3,RPS8,RPL5 andRPL25), twoRiBi genes function-
ally related to ribosomes, but which do not encode RPs
(RPA43 and RRP12), and four genes with no direct
functional link to ribosomes (ADH1, PHO88, HXT1 and
HXK2) (Figure 3A and Supplementary Figure S8A). TFIIS
ChIP signals were consistent and showed intensities that
were highly proportional to the amount of RNA polymer-
ase II present in the genes, as measured by Rpb3 ChIP
(Figure 3B and Supplementary Figure S8B). Addition of
6AU to cultures led to a decrease of TFIIS through the
four RP genes, HXT1 and HXK2, and to minor effects in
the other four genes (Figure 3A and Supplementary
Figure S8A). 6AU also brought about a rapid decrease of
the RNA polymerase II occupancy of the RP genes and
RRP12 across their entire length (Figure 3B and
Supplementary Figure S8B). This was not the case for the
other tested genes, which showed an accumulation of RNA
polymerase II at the 50-end, as previously described (4), with
no signiﬁcant decrease noted along the transcribed region
(Figure 3B and Supplementary Figure S8B). The compari-
son between the TFIIS and the Rpb3 ChIP results uncovers
a striking difference between ribosome-related genes and the
rest. Whereas RP genes, and to a lesser extent the two RiBi
genes, showed parallel changes of TFIIS and Rpb3 signals
in response to 6AU, the other four genes exhibited an im-
balance between Rpb3 and TFIIS upon 6AU addition
(Figure 3A–B and Supplementary Figure S8A–S8B).
In order to quantify the impact of 6AU on the transcrip-
tional availability of TFIIS, we calculated the average
TFIIS/Rpb3 ratio for each gene, normalized to the initial
value (before 6AU addition). We omitted the two RiBi
genes because of their very low Rpb3 ChIP values, close
to those of a non-transcribed control (Supplementary
Figure S8B). We found that the TFIIS/Rpb3 ratios
remained unchanged in the four RP genes upon the
addition of 6AU, whereas the RNA polymerases
transcribing the four non-ribosomal genes became
TFIIS-impoverished (Figure 3C). This difference detected
between RP and the non-ribosomal genes was observed
along the entire length of the genes (Supplementary
Figure S8C).
These results suggest a preferential binding of TFIIS to
those RNA polymerases transcribing RP genes upon 6AU
addition. In order to investigate whether this phenomenon
had any functional inﬂuence on RP transcription, we
monitored the variation of RNA polymerase II occupancy
in response to 6AU in the dst1D mutant. We found that
the RP genes underwent a slower RNA polymerase II
decrease in the mutant than in the wild-type, whereas
the non-RP genes behaved more similarly than the RP
genes in the two strains (Figure 4A). The difference for
Figure 3. TFIIS and RNA polymerase II occupancy in response to 6AU.
Changes in HA-TFIIS (A) and Rpb3 (B) binding to RNA polymerase
II-dependent genes in response to 6AU(100mg/ml). All the values represent
the average of three independent experiments at three different amplicons
distributed along the genes. Samples were taken from the same extracts to
analyse HA-TFIIS and Rpb3 in parallel. ChIP signals were quantiﬁed in
relation to the input material. The results of an untranscribed intergenic
region (Chromosome V, co-ordinates 9716–9863) are also shown. Error
bars indicate standard deviation. (C) Variation of TFIIS/RNA polymerase
II ratios upon6AU (100mg/ml) addition, asmeasured byChIP experiments
utilizing antibodies against HA-TFIIS and Rpb3. All the values represent
the average of three independent experiments and three different amplicons
[shown in (A) and (B)].
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RP genes between the dst1D and the wild-type became
particularly clear for the 50-end; the differential effect of
6AU on the Rpb3 proﬁles (from 50 to 30) that we detected
between RP and non-RP genes was milder in dst1D than in
the wild-type (Supplementary Figure S9A and S9B).
We measured the amount of the transcriptionally active
polymerases on the different genes tested by transcrip-
tional run-on. Unlike ChIP, which can detect any RNA
pol II molecule bound to DNA independently of its tran-
scriptional status, transcriptional run-on allows the
speciﬁc detection of those RNA polymerases actively
engaged in transcription, which do not take a backtracked
conﬁguration. We assumed that each active polymerase
produces a similar signal in the run-on assay irrespectively
of its position within the genome (34); accordingly, any
variation in the run-on signal of a gene would involve a
change in the number of active RNA polymerases actually
transcribing such a gene. In the wild-type, most of the
genes analysed were able to maintain their run-on
signals unchanged or close to initial values after 15min
in 6AU (Supplementary Figure S10A). In dst1D, all the
genes showed decreased run-on signals upon 6AU
addition, but this decrease was especially intense in the
four RP genes, whose proﬁles showed the largest differ-
ence when compared to the wild-type (Supplementary
Figure S10A).
The comparison made between Rpb3 ChIP and the
run-on results offer additional clues to interpret these
experiments. The speciﬁc reduction in RNA pol II occu-
pancy exhibited in the wild-type by RP genes after 15min
in the presence of 6AU (Figure 4A) was not reﬂected in
the density of the active polymerases measured by tran-
scriptional run-on (Supplementary Figure S10A). The
same comparison made in dst1D offers the opposite
outcome for RP genes: a slower decrease of Rpb3 than
the run-on (Figure 4A and Supplementary Figure S10A).
These results suggest that TFIIS plays an important role
in RP genes during NTP depletion by maintaining their
RNA polymerase II population fully active. The run-on/
Rpb3 ratios calculated for each gene conﬁrm a marked
increase of RNA polymerase II speciﬁc-activity (active
transcription/total RNA polymerase II) in the four RP
genes upon 6AU addition, which was absent in non-RP
genes (Figure 4B). After 90min in 6AU, a condition under
which the up-regulation of IMD2 must diminish NTP
stress, RP genes still exhibited higher run-on/Rpb3
ratios than the four control genes, although the difference
had diminished considerably (Figure 4B). In contrast,
RNA polymerase II speciﬁc-activity sharply dropped in
the dst1D cells in all the genes tested upon 6AU addition
(Figure 4B), thus conﬁrming that the higher run-on/Rpb3
ratios exhibited by the four RP genes in the wild-type
depend on TFIIS. We conclude that the sustained
TFIIS/RNA polymerase II ratio exhibited by RP genes
after NTP depletion is responsible for the high RNA
polymerase II-speciﬁc activity detected in these genes.
Consequences of the absence of TFIIS in the expression of
rDNA and RP genes
The differential effect of the absence of TFIIS in rDNA and
RP genes under NTP stress predicts an imbalance between
newly synthesized ribosome components (rRNAs and RPs)
and a general disarrangement in ribosome biogenesis. We
followed the changes in the levels of the rRNA precursor
35S and two RP mRNAs in response to 6AU addition. We
noted a transient decrease of 35S at 10–30min after
6AU addition, which is consistent with the detected
Figure 4. TFIIS sustains RNA polymerase II activity in RP genes under transcriptional stress. (A) Variation in the levels of the RNA polymerase II
bound to the indicated genes, caused by the addition of 6AU (100 mg/ml) to both the wild-type and an isogenic dst1D strain. All the values represent
the average of three independent experiments and three different amplicons distributed along the indicated genes (Supplementary Figure S9A
and S9B) normalized to time 0. (B) Variation in the speciﬁc activity of RNA polymerases sitting on the indicated genes caused by 6AU addition
(100 mg/ml) to the wild-type and to an isogenic dst1D strain. RNA polymerase II speciﬁc activity was expressed as the ratio between the variation in
transcriptional run-on signal (Supplementary Figure S10A) and the variation in the Rpb3 ChIP signal [shown in (A)].
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down-regulation of rDNA transcription (Figure 2B); a sub-
sequent transient decrease of RPS3 and RPL5 mRNAs
(60min) and a ﬁnal equilibrium between 35S and RP
mRNAs after 3 h in 6AU (Figure 5A). The mRNA levels
of a non-RP gene like ADH1 scarcely varied (Figure 5A).
In contrast to the wild-type, 35S rRNA accumulated
and produced a signiﬁcantly altered 35S/RP mRNAs
ratio in the absence of TFIIS (Figure 5B). This imbalance
could be the result of either the over-activation of RNAP I
transcription or the consequence of rRNA processing
impairment. In order to distinguish between these two
possibilities, we measured the levels of two different
intermediates downstream of 35S, 32S and 27SA. Under
standard conditions, the 32S and 27SA rRNAs levels
mirror those of 35S. Any accumulation of 35S over 32S
or 27SA indicates a defect in current ribosome biogenesis
(35). We found that the dst1D cells did not accumulate
signiﬁcant levels of 32S or 27SA rRNAs in the presence
of 6AU (Figure 5C), indicating that 35S accumulation was
not due to a late up-regulation of the rDNA transcription,
but was directly owing to a failure in ribosome biogenesis.
The results described so far support a direct and speciﬁc
role of TFIIS in the transcription of RP genes. According
to this view, the malfunction of RP transcription under
NTP stress may explain the impairment of ribosome
biogenesis. However, there is an alternative interpretation
of these data; we may argue that the role of TFIIS might
be indirect as it contributes to the recovery of NTP pools
via IMD2 induction. To test this hypothesis, we followed
the effect of 6AU on the RP mRNAs and 35S levels in an
imd2D mutant. We found that the RNA kinetics were
surprisingly similar to the wild-type, with a decay of all
the RNAs and a ﬁnal 35S/RP mRNAs equilibrium after
2 h (Figure 5D). In this mutant, ADH1 mRNA underwent
a severe, sustained decrease (Figure 5D). These results
support the direct role of TFIIS, not mediated by the
expression of IMD2, in balancing the transcription of
those genes encoding ribosomal components.
sfp1D overcomes the requirement of TFIIS in RP genes’
response to NTP depletion
We also followed the levels of RP mRNAs and 35S upon
6AU addition in sfp1D and in the double dst1D sfp1D
mutant. We observed that the 35S and the RP mRNA
levels in sfp1D lowered less intensely than in the wild-type
(Figure 5E). Accordingly, an imbalanced 35S/RP mRNAs
ratio upon 6AU addition was never observed in the
double mutant (Figure 5F). These results suggest that
sfp1D is able to prevent the deleterious effects produced
by 6AU on RP genes transcription in the absence of
TFIIS.
In order to conﬁrm this hypothesis, we analysed the
transcriptional response of both RP and non-RP genes
to 6AU in both sfp1D and dst1D sfp1D. Unlike the
marked decrease detected in the RNA pol II occupancy
of RP genes upon 6AU addition in the wild-type
(Figure 4A), a reduction of only 20% was observed in
sfp1D (Figure 6A). Likewise, the RNA pol II decrease of
the four RP genes in dst1D (Figure 4A) was absolutely
abolished in dst1D sfp1D (Figure 6A). Similar results
were obtained with the run-on assay (Supplementary
Figure S10B). Consequently upon 6AU addition, the
run-on/Rpb3 ratios of the RP genes in sfp1D and in
dst1D sfp1D did not undergo any signiﬁcant variation
that was comparable to those underwent by the same
genes in the wild-type or in dst1D (compare Figures 4B
and 6B). We conclude that RP genes’ transcriptional be-
haviour changes in the absence of Sfp1, to such an extent
that it enables them to remain active in the presence of
6AU, independently of TFIIS.
This change might merely consist in a general
down-regulation of the number of initiating RNA pol II
molecules, as deduced from the low Rpb3 ChIP signals of
the RP genes in sfp1D and dst1Dsfp1D (Supplementary
Figure S9C and S9D). However, our results provide some
clues to suggest that Sfp1’s transcriptional role could go
beyond merely regulating RP genes’ RNA pol II initiation.
One intriguing ﬁnding is that the absence of Sfp1 not only
abolishes RP and non-RP genes’ differential response to
6AU, but also seems to modify non-RP genes’ transcrip-
tional response to 6AU. Several lots of data support this
view. Firstly, non-RP genes also showed lower levels of
RNApol II in sfp1D and dst1Dsfp1D (Supplementary
Figure S9C and S9D). No accumulation of RNA polymer-
ase II at the 50 of non-RP genes was observed in either sfp1D
or dst1D sfp1D (Supplementary Figure S9C–D). Moreover,
no decrease in either RNA pol II occupancy or the run-on
signal was observed for non-RP genes in dst1Dsfp1D, even
after 90min in the presence of 6AU (Figure 6A and
Supplementary Figure S10B). Accordingly, the run-on/
Rpb3 ratios of the non-RP genes in dst1D sfp1D did not
change upon 6AU addition (Figure 6B), which contrasts
to their signiﬁcant variation in dst1D (Figure 4D).
Finally, the run-on signals and run-on/Rpb3 ratios of the
non-RP genes in sfp1D increased after 90min in the
presence of 6AU (Figure 6B and Supplementary
Figure S10B). All these data suggest a general effect of
Sfp1 on elongation by RNA polymerase II, which is
especially relevant for the transcription of RP genes.
DISCUSSION
This work shows that sensitivity to NTP-depleting drugs
caused by the absence of TFIIS can be suppressed by the
mutation of some of the genes affecting the regulation of
ribosome biogenesis. This suppression even takes place
under conditions in which IMD2 is not signiﬁcantly
up-regulated, indicating that a change in RP genes’ expres-
sion allows RNA pol II-dependent transcription to
support cell growth in the absence of TFIIS and under
severe NTP stress. Accordingly, we propose that TFIIS
is required particularly for the transcription of RP genes
under NTP-depletion conditions.
The detailed transcriptional analysis of some RP genes
supports this view. We found that, upon 6AU treatment,
the TFIIS/RNA pol II ratios of RP genes are substan-
tially higher than those exhibited by non-ribosomal genes,
including strongly transcribed ADH1 (Figure 3C). As a
recent structural work reveals, the TFIIS–RNA pol II
complex is incompatible with the RNA polymerization
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Figure 5. TFIIS is required for the balance between rDNA transcripts and RPs mRNAs. Northern blots showing the variation of the 35S primary
rRNA precursor and the mRNAs of the indicated genes upon 6AU addition (100 mg/ml) in the wild-type (A) and in the dst1D (B), imd2D (D), sfp1D
(E) and dst1Dsfp1D (F) isogenic strains. The quantiﬁcations for 35S and RPL5 mRNA are shown in order to visualize the 35S/RP mRNA balance.
(C) Levels of the 35S, 32S and 27SA rRNA precursors measured by Northern blot upon 6AU addition (100 mg/ml) in the wild-type and in an
isogenic dst1D strain. Note that the accumulation of 35S detected in dst1D is not coupled with a similar accumulation of either 32S or 27SA, as
would be expected for a general increase in rDNA transcription. 18S rRNA is shown as the loading control in all the panels.
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reaction (36). Accordingly TFIIS, recruitment likely
responds to a previous backtracked conﬁguration, and
should involve the reactivation of arrested RNA polymer-
ases. In fact, the preferential occupancy of RP genes by
TFIIS in response to 6AU (Figure 3C) agrees with the
strongly increased RNA pol II speciﬁc-activity found in
RP genes, as reﬂected by the run-on/Rpb3 ratios
(Figure 4B). The simplest explanation for this correlation
is that TFIIS is preferentially recruited to those
elongating RNA pol II molecules which become back-
tracked in RP genes when NTPs are scarce. This hypoth-
esis involves a greater tendency of RNA pol II to become
backtracked in RP genes than in non-RP genes. This is, in
fact, one of the conclusions drawn by a previous study
from our lab, which revealed that RP genes exhibit the
highest RNA pol II ChIP/run-on ratios throughout the
genome, interpreted as the highest proportion of arrested
RNA pol II (25). Similarly, a nascent elongating tran-
script sequencing (NET-seq) database has revealed a
high frequency of pausing in RP genes (14).
Alternatively, the relatively high TFIIS/Rpb3 ratios ex-
hibited by RP genes upon 6AU treatment could well be
the result of a longer resident time of the TFIIS–RNApol
II complexes under down-regulation conditions.
Reactivated RNApol II (after RNA cleavage) has been
described to stay in place for a time before resuming tran-
scription (14). One possible cause for this delay may be
the slow kinetics of TFIIS dissociation. In a
down-regulation situation of RP genes, provoked by
NTP stress, this slow TFIIS off-rate could involve a tran-
sient enrichment in the TFIIS–RNA pol II complexes,
these being competent complexes for run-on. In either
of the alternative explanations we offer herein, the
higher TFIIS/Rpb3 ratios exhibited by RP genes and
the differential effect of dst1D indicate a crucial role for
TFIIS in the transcription of RP genes.
Our aforementioned work also demonstrated that the
RNA pol II ChIP/run-on ratio of RP genes could be
regulated. Mutants like tpk2D, affecting RP genes’
response to the Ras–PKA pathway, or RAP1DSIL, affect-
ing the main gene-speciﬁc transcription factor of RP
genes, caused a substantial increase in the proportion of
active RNA pol II (run-on signal) without changing the
relative amount of bound polymerase (ChIP signal) (25).
We thought it most signiﬁcant that the same mutations
could suppress the sensitivity of dst1D to 6AU
(Supplementary Figure S6). The silencing domain of
RAP1 is able to recruit SIR proteins which, in turn,
contribute to the formation of a high-order silent chroma-
tin structure (37). Its genetic interaction with TFIIS
suggests a role of heterochromatic chromatin in RP
genes’ transcriptional behaviour. In a different study, we
also described how RP genes display the lowest 30/50 ratios
of active transcription (measured by run-on) of the yeast
genome (28). All these data indicate that the likelihood of
RNA pol II molecules pausing and backtracking is greater
in RP genes than in most other genes and, therefore, the
requirement of TFIIS is maximal in RP genes.
As stated in the ‘Results’ section, we assume that all the
RNA polymerase II molecules are able to produce similar
run-on signals, at least on average.We base this assumption
on the stringent run-on assay conditions, which should
Figure 6. Deletion of SFP1 almost eliminates the response of RNA polymerase II-dependent genes to 6AU, even in the absence of TFIIS.
(A) Variation in the levels of the RNA polymerase II bound to the indicated genes, caused by the addition of 6AU (100 mg/ml) to sfp1D and
dst1Dsfp1D cells. All the values represent the average of three independent experiments and three different amplicons distributed along the indicated
genes (Supplementary Figure S9C and S9D). (B) Variation in the speciﬁc activity of the RNA polymerases sitting on the indicated genes caused by
the addition of 6AU (100 mg/ml) to the sfp1D and dst1Dsfp1D cells. RNA polymerase II-speciﬁc activity was expressed as the ratio between variation
in the transcriptional run-on signal (Supplementary Figure S10B) and variation in the Rpb3 ChIP signal [shown in (A)]. Scales were set to facilitate a
comparison to Figure 4A and B, respectively.
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provide a homogenous template (nucleosome-free DNA)
for each elongating RNA polymerase (34). Alternative in-
terpretations of the run-on signal variation, i.e. a different
length of the run-on transcript, would change the molecular
meaning of our results, but would not change the main
message of this work: the differential transcriptional behav-
iour of the RNA pol II molecules when transcribing RP
genes and their higher dependency on TFIIS in comparison
with other highly transcribed genes.
It has been recently demonstrated that backtracking
and RNA cleavage are very common phenomena and
that they are likely consubstantial to RNA pol
II-dependent transcription in vivo (3,14). This is in good
agreement with previous in vitro experiments (13).
However, life without TFIIS is possible in yeast under
standard growing conditions since dst1D mutants are
viable. This viability is explained by the basal intrinsic
cleavage activity of RNA pol II, which takes place even
in the absence of the stimulatory inﬂuence of TFIIS (2,3).
Yet under NTP-depleting conditions, the frequency of
backtracking in RP genes in the absence of TFIIS would
be so high that cells would undergo a RP shortage and
would eventually become unviable. This RP shortage
occurring in dst1D is reﬂected by the imbalance between
35S and RP mRNAs. RNA pol I ChIP data do not
suggest that this imbalance is caused by the up-regulation
of rDNA Transcription (Figure 2B). Other rRNA inter-
mediates, like 32S and 27SA, do not accumulate in parallel
to 35S (Figure 5C). All together, these results not only
indicate a serious problem in rRNA processing caused
by 6AU in dst1D, but favour the conclusion that TFIIS
contributes to the coordination of the genome fraction
which encodes ribosomal elements.
According to the transcriptional analysis that we per-
formed, the role of TFIIS in RP genes’ response to 6AU is
sufﬁcient to explain the defect detected in rRNA biogen-
esis. TFIIS might also be involved in the transcriptional
response of ribosome biogenesis factors to NTP depletion.
However, the suppression of dst1D sensitivity to
NTP-depleting drugs by the mutations in RAP1 does
not support this possibility since Rap1 is a transcription
factor that regulates almost every RP gene, but does not
bind most RiBi promoters. We conclude that RP genes are
the main targets of TFIIS in the response of ribosome
biogenesis to 6AU. Nevertheless, a role of TFIIS in RiBi
genes under transcriptional stress cannot be ruled out.
TFIIS seems to be partially dispensable to resist
NTP-depleting drugs in the absence ofDAS genes, including
the RP genes regulators SFP1 and SCH9. Sch9 is the yeast
homologue of mammalian Akt/PKB and regulates stress-
resistance by the activation of stress-responsive genes
(38,39). Sfp1 controls the transcription of ribosomal-
related genes in response to nutrients (40). Communication
of the growth potential to ribosome synthesis is a common
role of Sch9 and Sfp1 (30) since other targets of Sch9 are not
inﬂuenced by Sfp1 (41), and since sfp1D and sch9D exhibits
opposite phenotypes in response to other environmental
signals (42). This fact suggests that das mutations cause
major alterations in the regulatory mechanisms of riboso-
mal genes to the extent that the arrest-prone scenario of RP
genes would be prevented, thus alleviating their dependency
on TFIIS under NTP stress.
We investigated the case of sfp1D and shown that this
mutation suppresses the imbalance between 35S and RP
mRNAs provoked by 6AU in the absence of TFIIS
(Figure 5). This result suggests that sfp1D is able to
rescue RP transcription from TFIIS-dependency since
TFIIS does not play a functional role in the response of
rDNA to 6AU (Figure 2B). This is exactly what we found:
when Sfp1 is absent, RP transcription is not signiﬁcantly
affected by 6AU in either a dst1D or a wild-type back-
ground (Figure 6). A simple explanation for these results
would involve a transcriptional function of Sfp1 upstream
of TFIIS and in an antagonist fashion, which would
favour RNA polymerase II backtracking.
One unexpected result we found is the general effect of
sfp1D. All the tested genes (RP and non-RP) were almost
insensitive to 6AU in the absence of Sfp1. So far, all the
transcriptional functions of Sfp1 had been restricted to RP
genes. The general effects we detected of Sfp1 may prove
to be an indirect result of its role in RP regulation.
Alternatively, Sfp1 might perform a more general
function in RNA pol II-dependent transcription which,
in the case of RP genes, would be especially relevant for
their expression.
The presentwork describes howTFIIS plays an important
regulatory role for a fraction of the yeast genome (RP genes)
whose transcription is modulated by RNA pol II inactiva-
tion/reactivation during elongation (25). Gene-expression
regulation at the transcription elongation level is, in fact, a
very common phenomenon in metazoa. It is tempting to
predict a general regulatory role for TFIIS in higher
eukaryotes, as already demonstrated for the heat shock
genes in Drosophila (43) and for the growth-promoting
genes in humans (44).
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